Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The company traded as high as $316.50 and last traded at $299.10, with a volume of 1207917 shares trading hands. The stock had previously closed at $306.88.
Wall Street Analyst Weigh In
Several analysts have weighed in on ALAB shares. Needham & Company LLC upped their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Morgan Stanley upped their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday. JPMorgan Chase & Co. upped their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Finally, UBS Group initiated coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective on the stock. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $233.75.
Check Out Our Latest Stock Analysis on Astera Labs
Astera Labs Stock Up 2.9%
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.
Insider Activity at Astera Labs
In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,915,461 shares of company stock worth $358,508,976 over the last 90 days. Insiders own 12.50% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Verus Capital Partners LLC boosted its position in shares of Astera Labs by 16.4% in the 1st quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock worth $422,000 after purchasing an additional 541 shares during the last quarter. Liontrust Investment Partners LLP boosted its holdings in Astera Labs by 98.7% during the first quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock worth $11,538,000 after buying an additional 52,284 shares during the last quarter. SOA Wealth Advisors LLC. bought a new position in Astera Labs during the first quarter worth about $49,000. E20 Capital Ltd bought a new position in Astera Labs during the first quarter worth about $33,310,000. Finally, Silicon Valley Capital Partners boosted its holdings in Astera Labs by 233.3% during the first quarter. Silicon Valley Capital Partners now owns 1,000 shares of the company’s stock worth $110,000 after buying an additional 700 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
- 3 Defense Giants Boosting Dividends as Shares Take a Ride
- Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026
- Quantum Stocks Just Got a Lifeline—Who Benefits Most?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
